Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 921 in Lipitor, Atorvastatin (generic)

  1. South Carolina Litigation to Discuss Federal Lipitor Lawsuits at...Read the original story w/Photo

    Jan 1, 2015 | PRWeb

    Our Firm is looking forward to the federal Lipitor litigation's upcoming status conference, as we continue to hear from individuals who allegedly developed diabetes after taking Lipitor. A federal litigation that includes hundreds of Lipitor lawsuits is looking ahead to a status conference in January that will take place in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports.

    Comment?

  2. Pfizer, Home of Lipitor and Viagra, Lifts DividendRead the original story w/Photo

    Dec 31, 2014 | Investor's Business Daily

    Pfizer will dole out the dividend on March 3 to shareholders of record Feb. 6. With this rise, Pfizer's dividend will have grown more than 50% in the past four years. When distributed, it would be the company's 305th quarterly dividend to stockholders.

    Comment?

  3. Lipitor Lawsuits Approach 1,500 in South Carolina Litigation,...Read the original story w/Photo

    Dec 29, 2014 | PRWeb

    The number of lawsuits alleging Lipitor diabetes complications continues to increase in the District of South Carolina, where a multidistrict litigation is underway. Our Firm is not surprised to see the number of Lipitor lawsuits in South Carolina federal court continue to increase.

    Comment?

  4. Florida State vs. Oregon: Who Is the Better 2nd-Half Team?Read the original story w/Photo

    Dec 24, 2014 | BleacherReport

    With nine come-from-behind victories this season, it would seem as though the third-ranked Florida State Seminoles are the best second-half team in the nation. But is that really the case? Perhaps it is the second-ranked Oregon Ducks, Florida State's Rose Bowl opponent, that are the team to beat in the second half.

    Comment?

  5. Cholesterol-lowering drugs cause dissolution of cholesterol crystals...Read the original story

    Dec 24, 2014 | CiteULike

    Cholesterol crystals form within hepatocyte lipid droplets in human and experimental NASH and are the focus of crown-like structures of activated Kupffer cells . Obese, diabetic Alms1 mutant mice were fed high-fat diet containing 0.2% cholesterol for 16 weeks and then assigned to 4 intervention groups for 8 weeks: a.

    Comment?

  6. Use of cholesterol-lowering meds on the riseRead the original story w/Photo

    Dec 24, 2014 | Fox News

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.

    Comment?

  7. Use of Cholesterol-Lowering Meds on the RiseRead the original story w/Photo

    Dec 22, 2014 | LiveScience

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.

    Comment?

  8. Statins cause brain dysfunctionRead the original story w/Photo

    Dec 22, 2014 | NewsTarget.com

    Statins are the most profitable medications in the history of Big Pharma. They are promoted as the go-to medications to prevent/treat heart disease.

    Comment?

  9. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking...Read the original story

    Dec 19, 2014 | Personal Injury Law News

    The study's publication comes amid a growing number of Lipitor lawsuit filings on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of the cholesterol-lowering statin.

    Comment?

  10. AstraZeneca will outsource Crestor API following UK plant closureRead the original story w/Photo

    Dec 19, 2014 | Drug Researcher

    The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said. The decision to shutter the Avlon plant, near Bristol, was originally taken in 2008 but this week the company told our sister publication in-Pharmatechnologist.com the site would close its doors by early 2017.

    Comment?

  11. 3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.Read the original story w/Photo

    Dec 19, 2014 | The Motley Fool

    It's no secret why: Pfizer has a well-diversified portfolio of pharmaceuticals products that tend to perform well in robust as well as recessionary environments. However, there's one big problem with Pfizer : It's currently suffering from a monstrous patent cliff whereby some of its key drugs are losing their exclusivity and being exposed to generic competition, which costs just a fraction of what branded drugs usually run.

    Comment?

  12. Selecting a Database for Drug Literature Retrieval: A Comparison of...Read the original story

    Dec 18, 2014 | CiteULike

    Three widely used databases?MEDLINE, Scopus, and Web of Science?were compared for their relative ability to retrieve the largest number of articles within the drug literature, using three search terms: two for specific drugs and one for a major class of drugs . These drugs and the class of drugs were chosen for their longevity and continued high clinical and scientific interest, as indicated by the many articles concerning them published in scholarly and professional journals over the last two decades.

    Comment?

  13. AstraZeneca API plant set to shut by 2017 as Patent Cliff strikes againRead the original story w/Photo

    Dec 18, 2014 | In-PharmaTechnologist.com

    An AstraZeneca API plant in Bristol, UK will close its doors within two years due to patent expirations of its cholesterol-lowering blockbuster Crestor. 2013 sales of AstraZeneca's cardiovascular drug Crestor decreased 8% on the previous year to $5.6bn due to erosion from patent expiration in certain markets.

    Comment?

  14. Did You Take These Drugs?Read the original story w/Photo

    Dec 17, 2014 | OpEdNews

    It's no secret that direct-to-consumer drug advertising made drugs like Viagra, Lipitor, Prozac or Nexium into rock stars. What is less apparent is how many new drugs betrayed serious risks after millions took them.

    Comment?

  15. Rise Of The Indian Drug Industry Demands Improved RegulationRead the original story w/Photo

    Dec 17, 2014 | The Daily Caller

    A major Indian biotechnology company just announced it is breaking into the exciting field of biologic medicines. Zydus-Cadila has successfully manufactured a rough copy of a popular autoimmune disease biologic called Humira.

    Comment?

  16. London Sewer Cleaners Fighting FatbergsRead the original story w/Photo

    Dec 16, 2014 | Patch.com

    London Sewer Cleaners Fighting Fatbergs: Every day beneath the streets of London, sewer technicians are fighting a grim war against giant 'fatbergs' - or accumulated fat pockets in the sewers caused by people dumping grease such as turkey fat down their sinks - which clog the system and threaten to regurgitate putrid waste back into people's homes. All I know is, finding those fat deposits must have required one hell of a colonoscopy.

    Comment?

  17. Is This The Future Of Late-Stage Drug Development?Read the original story w/Photo

    Dec 15, 2014 | Forbes.com

    As DrugBaron, I have blogged extensively on healthcare generally, and the pharma industry in particular, over the last five years. I am a Partner at Index Ventures, based in London, with particular focus on company creation and early stage investment in the life sciences, building on my experience over twenty years as an academic at Cambridge University.

    Comment?

  18. 3 Traits of the Best Healthcare Stocks in 2014Read the original story w/Photo

    Dec 15, 2014 | The Motley Fool

    Just when it looked as though the stock market couldn't possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad bit higher than the stock markets' historic annual return.

    Comment?

  19. A costly anomaly on a brain MRIRead the original story w/Photo

    Dec 14, 2014 | Kevin, M.D.

    It started with a mild case of nausea and got progressively worse. I became dizzy and shaky, but tried to ignore it.

    Comment?

  20. Early statin use may give long-term heart benefitsRead the original story w/Photo

    Dec 14, 2014 | Crescent-News.com

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds.

    Comment?